STAT+: Eli Lilly launches program for employers to subsidize cost of obesity drug outside insurance
Eli Lilly is going beyond its efforts to sell its obesity drug Zepbound directly to patients, and is now trying to target employers. Over a year ago, Lilly launched LillyDirect, an online platform that allows patients to buy Zepbound for a cash price of up to $449 a month with...
🔗 Read more: https://www.statnews.com/2026/03/05/eli-lilly-zepbound-employers/?utm_campaign=rss
#News #Health #Software #Medicine #Science
Edited
www.statnews.com
STAT+: Eli Lilly launches program for employers to subsidize cost of obesity drug outside insurance
Eli Lilly is going beyond its efforts to sell its obesity drug Zepbound directly to patients, and is now trying to target employers. Over a year ago, Lilly launched LillyDirect, an online platform that allows patients to buy Zepbound for a cash price of up to $449 a month without using insurance....
Comments
Log in to leave a comment.
No comments yet. Be the first to comment!